International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 1629-1632
Original Article
Prevalence and Pattern of Anemia in Patients with Primary Hypothyroidism - A Hospital- Based Study
 ,
 ,
 ,
Received
Dec. 8, 2025
Accepted
Dec. 20, 2025
Published
Dec. 25, 2025
Abstract

Context: Anemia frequently accompanies hypothyroidism but its prevalence and morphological patterns vary across studies¹².

Aim: To determine the prevalence and pattern of anemia in patients with primary hypothyroidism and compare findings with healthy controls³.

Methods: Cross-sectional, hospital-based study⁴. Newly diagnosed primary hypothyroid patients aged 18–65 and age/sex-matched euthyroid controls were enrolled. Clinical evaluation, complete blood count with peripheral smear, thyroid function tests and targeted tests to classify anemia were performed⁵. Anemia severity was defined by WHO criteria⁴. Data were analyzed using SPSS; p < 0.05 considered significant.

Results: A total of 250 participants were studied (130 cases, 120 controls). Prevalence of anemia among hypothyroid cases was 76.9% (100/130) vs 41.7% (50/120) in controls⁵⁶. Severity in cases: mild 20%, moderate 36%, severe 44%. Peripheral smear morphology among anaemic cases: microcytic hypochromic 38%, normocytic normochromic 25%, macrocytic 18%, dimorphic 13%, others 6%. A significant correlation was observed between severity of anemia and type of hypothyroidism (p = 0.003).

Conclusions: Anemia is highly prevalent in patients with primary hypothyroidism compared to euthyroid controls⁷⁻⁹.

Keywords
INTRODUCTION

Thyroid hormones regulate erythropoiesis by modulating erythropoietin synthesis and bone marrow activity²⁹. Hypothyroidism is associated with a spectrum of hematological abnormalities, most commonly anemia, through multifactorial mechanisms including decreased erythropoietin production, iron deficiency (menorrhagia or malabsorption), and autoimmune associations⁸. Epidemiological studies report variable prevalence of anemia in hypothyroid patients; hospital-based Indian series report figures in the range of 20–80% depending on selection criteria and workup depth¹⁵⁶. Given this heterogeneity, region-specific data are valuable to guide screening and management strategies. This study evaluated the prevalence, severity and morphological patterns of anemia among patients with primary hypothyroidism in a tertiary care hospital in North India.

 

MATERIALS AND METHODS

Study design and setting: Cross-sectional, observational, hospital-based study conducted at the Department of General Medicine, Government Medical College, Baramulla.

 

Participants: Newly diagnosed adult patients (18–65 years) with primary hypothyroidism (overt and subclinical) were recruited as cases. Age- and sex-matched euthyroid healthy volunteers served as controls. Patients with pre-existing anemia under treatment, chronic kidney disease, active bleeding, malignancy, pregnancy, or on thyroid/hematinic therapy were excluded.

 

 

Definitions and laboratory methods: Primary hypothyroidism was defined as elevated serum TSH with or without low free T4; subclinical hypothyroidism as elevated TSH with normal free T4; overt hypothyroidism as elevated TSH with low free T4. Serum TSH, free T3 and free T4 were measured by chemiluminescence immunoassay. Complete blood count was performed on an automated 5-part haematology analyzer and peripheral smear interpreted with Leishman/Giemsa stained slides. Iron studies, vitamin B12 and folate were done wherever clinically indicated. Anemia severity was graded according to WHO criteria⁴.

 

Ethical considerations: The study received approval from the Institutional Ethics Committee of Government Medical College, Srinagar S Scientific committee Government medical College, Baramulla. Written informed consent was obtained from all participants.

 

Statistical analysis:

Data were entered into Microsoft Excel and analyzed using SPSS version 20. Categorical variables are presented as frequencies and percentages; continuous variables as mean ± SD where appropriate. Chi-square test was used for categorical comparisons and Pearson correlation for associations. A p-value < 0.05 was considered statistically significant.

 

RESULTS

A total of 250 participants were included: 130 patients with primary hypothyroidism (cases) and 120 age- and sex-matched euthyroid controls. Among cases, 70 (53.8%) had overt hypothyroidism and 60 (46.2%) had subclinical hypothyroidism. The gender distribution among cases was 97 (74.6%) females and 33 (25.4%) males; controls comprised 68 (56.7%) females and 52 (43.3%) males.

 

Prevalence of anemia was significantly higher in hypothyroid cases: 100/130 (76.9%) compared with 50/120 (41.7%) in controls (Table 1 S Figure 1). Severity distribution among anaemic cases was: mild 20 (20%), moderate 36 (36%), and severe 44 (44%) (Table 2). Controls had milder anemia overall.

 

Peripheral smear morphology among the 100 anaemic cases was: microcytic hypochromic 38 (38%), normocytic normochromic 25 (25%), macrocytic 18 (18%), dimorphic 13 (13%), and others 6 (6%) (Table 3). Severity of anemia correlated significantly with type of hypothyroidism (p = 0.003); gender also showed an association (p = 0.036) while age did not (p = 0.549).

 

Table 1. Prevalence of anemia in cases and controls.

Group

N

Anaemic, n (%)

Non-anaemic, n (%)

Cases (Hypothyroid)

130

100 (76.9)

30 (23.1)

Controls (Euthyroid)

120

50 (41.7)

70 (58.3)

 

Table 2. Severity of anemia in cases vs controls

Severity

Cases (n=100) n (%)

Controls (n=50) n (%)

Mild

20 (20.0)

22 (44.0)

Moderate

36 (36.0)

24 (48.0)

Severe

44 (44.0)

4 (8.0)

 

Table 3. Peripheral smear morphology among anaemic cases.

Morphological type

n (%)

Microcytic hypochromic

38 (38%)

Normocytic normochromic

25 (25%)

Macrocytic

18 (18%)

Dimorphic

13 (13%)

Others

6 (6%)

 

Table 4. Type of hypothyroidism among cases.

Type of hypothyroidism

n (%)

Overt hypothyroidism

70 (53.8%)

Subclinical hypothyroidism

60 (46.2%)

 

Figures

 

Figure 1. Prevalence of Anemia: Cases vs Controls.

 

Figure 2. Severity of Anemia: Cases vs Controls.

 

Figure 3. Peripheral Smear Morphology in Anaemic Cases.

 

DISCUSSION

In this hospital-based cohort, anemia was significantly more prevalent among patients with primary hypothyroidism (76.9%) compared to euthyroid controls (41.7%). This high prevalence is in line with several Indian hospital-based reports¹⁵⁶ and supports the notion that thyroid dysfunction contributes meaningfully to hematological morbidity. The predominant morphologies — microcytic hypochromic and normocytic normochromic — suggest that both iron deficiency and hypoproliferative mechanisms (reduced erythropoietin effect) play roles in this population²⁶. Overt hypothyroidism showed greater association with severe anemia, consistent with prior observations³⁷.

 

Clinical implications: Routine hematological screening should be considered in patients diagnosed with hypothyroidism. Conversely, thyroid function tests should be part of the evaluation in unexplained anemia, especially when conventional causes are not evident.

 

Strengths and limitations: Strengths include a well-defined control group and peripheral smear-based morphological classification. Limitations are single-center design, lack of universal iron/B12 testing in all participants (tests were done when clinically indicated), and inability to provide longitudinal follow-up to assess response to thyroid replacement therapy.

 

CONCLUSION

Anemia is common in primary hypothyroidism and often moderate to severe. Microcytic hypochromic and normocytic normochromic patterns predominate. Clinicians should screen for anemia in hypothyroid patients and consider thyroid testing in unexplained anemia.

 

Acknowledgements

We acknowledge the support of the faculty and laboratory staff at Government Medical College, Baramulla, and the patients who consented to participate in the study.

 

REFERENCES

  1. Das C, et Prevalence of anemia in hypothyroidism: A hospital-based study. J Assoc Physicians India. 2019;67(6):42-47.
  2. Erdogan M, et Anemia in hypothyroidism and its correlation with thyroid hormone levels. Endocr J. 2017;64(5):473-479.
  3. Hollowell JG, et Serum TSH, T(4), and thyroid antibodies in the US population (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
  4. World Health Haemoglobin concentrations for the diagnosis of anemia and assessment of severity. Geneva: WHO; 2011.
  5. Reddy VC, et Study of hematological profile in patients with hypothyroidism. Indian J Clin Biochem. 2021;36(1):101-107.
  6. Verma M, et Evaluation of anemia in hypothyroid patients: A cross-sectional study from North India. Thyroid Res Pract. 2020;17(2):74-79.
  7. Solanki S, et Spectrum of anemia in thyroid dysfunction: A tertiary care experience. Int J Adv Med. 2022;9(5):534-540.
  8. Mishra A, et Correlation between thyroid dysfunction and hematological abnormalities. Indian J Endocr Metab. 2018;22(5):695-699.
  9. Kumar P, et Relationship between thyroid function and red cell indices in hypothyroid patients. Biomed Res Int. 2023; Article ID 7456923.
Recommended Articles
Original Article Open Access
Evaluation of Doppler Parameters of Ophthalmic Artery and Central Retinal Artery in Type 2 Diabetes Mellitus for Early Detection of Diabetic Retinopathy with Fundoscopic Correlation
2025, Volume-6, Issue 6 : 1708-1715
Original Article Open Access
Prevalence and Clinical Profile of Autoimmune Hypothyroidism in Adult Patients Attending a Tertiary Care Hospital
2025, Volume-6, Issue 6 : 1625-1628
DOI: 10.5281/zenodo.18066772
Original Article Open Access
Incomplete and Accessory Pulmonary Fissures: Gross Anatomical Variations and Their Clinical Implications
2025, Volume-6, Issue 6 : 1669-1676
Original Article Open Access
An open labeled randomized double armed controlled clinical study on Nava Kashaya and Shirisha Twak Lepa on Dadru Kustha w.s.r Tinea corporis
2025, Volume-6, Issue 6 : 1633-1647
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
10 Views
9 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved